Ranibizumab 0.5 mg in Asian patients with visual impairment due to macular edema secondary to central retinal vein occlusion: Results from the 12-month CAMELLIA study

Category Primary study
JournalInvestigative Ophthalmology and Visual Science
Year 2017
This article has no abstract
Epistemonikos ID: 4b64ce541e650953043efc2bfdffef229e0439e1
First added on: Feb 09, 2025